A 3-day international conference connecting research, clinical care, and advocacy in autism spectrum disorder and Fragile X–associated conditions across the U.S., Egypt, and the MENA region.
NeuroConnect Conference brings together scientists, clinicians, trainees, and families to advance understanding of autism spectrum disorder, Fragile X syndrome, and related neurodegenerative conditions. Hosted in Cairo, the conference strengthens collaboration between the United States and Egypt, translating research into meaningful clinical and community impact.
Global Program
Expert Speakers
Participants
AUC & NRC
This event is designed to empower you with actionable insights and hands-on experiences
Engage with world-leading researchers and clinicians in Fragile X, autism, and neurogenetics.
Connect professionals and families across the U.S., Egypt, and the MENA region.
Translate research findings into practical tools for diagnosis, treatment, and support.
Support trainees, students, and early-career professionals shaping the future of neurodevelopmental care.
Featuring world-renowned experts in Fragile X, autism, and neurodevelopmental research, sharing insights from science, clinical care, and advocacy.
7+ Professional event speakers involved






Choose the experience that fits your role — researcher, clinician, student, or family advocate.
Ideal for students & families
For clinicians, researchers & professionals
Limited availability
An outstanding platform connecting research with real clinical impact.

Clinical Researcher
The diversity of speakers and the focus on Fragile X and autism made this event incredibly meaningful. It created a space for learning, advocacy, and genuine collaboration.

Parent Advocate
An exceptional platform that brings together international expertise and regional perspectives. NeuroConnect fosters dialogue that translates science into real-world impact.

Public Health Professional
Join a global community shaping the future of neurodevelopmental research, care, and advocacy.
Dr. Reem Olaby is a pharmacist, scientist, and higher-education leader actively engaged in curriculum reform, faculty development, and academic governance.
Her scholarly work focuses on the genetic, epigenetic, and proteomic underpinnings of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), Fragile X syndrome (FXS), and Fragile X–associated tremor/ataxia syndrome (FXTAS).
She is dedicated to translating molecular research into impactful education strategies, clinical training initiatives, and interdisciplinary collaboration.
Research Focus :
NeuroConnect stands out as a conference that truly connects research with lived experience. The sessions were informative, compassionate, and highly relevant to both clinicians and families.